ENG
ENG KOR

Our Science

NEX-I, First-In-Class Cancer Immunotherapy Development Company

Pipeline

Project Target Indication Target market
position Partner Discovery Candidate
optimization Pre-clinical Phase I/II
NXI-101
ONCOKINE-1
Solid Cancer
FIC
NXI-201
ONCOKINE-2
Solid Cancer
FIC
NXI-301
ONCOKINE-3
Solid Cancer
FIC
NXI-M01
Myeloid cells
Solid Cancer
FIC
NXI-C01
Undisclosed
Solid Cancer
FIC

*FIC : First-In-Class

NEX-I, Inc.

HQ office : A-923 9F, Tera tower 2, 201 Songpa-daero, Songpa-gu, Seoul, 05854, Republic of Korea R&D Center : A-901 9F, Tera tower 2, 201 Songpa-daero, Songpa-gu, Seoul, 05854, Republic of Korea TEL : +82-2-6951-0412 FAX : +82-2-6951-0425

Copyright © 2021 nex-i. All rights reserved.

CONTACT